97 related articles for article (PubMed ID: 2376377)
1. [Quantitative determination of 5 vitreal proteins in the normal vitreous body and proliferative retinal diseases].
Clausen R; Weller M; Hilgers RD; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1990; 87(3):283-6. PubMed ID: 2376377
[TBL] [Abstract][Full Text] [Related]
2. [Protein composition of the vitreous body in proliferative diabetic retinopathy. An analysis with 2-D-electrophoresis].
Bresgen M; Baum U; Esser P; Wiedemann P; Heimann K
Ophthalmologe; 1994 Dec; 91(6):758-62. PubMed ID: 7849428
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
4. Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders.
Esser P; Bresgen M; Fischbach R; Heimann K; Wiedemann P
Ger J Ophthalmol; 1995 Sep; 4(5):269-74. PubMed ID: 7496336
[TBL] [Abstract][Full Text] [Related]
5. An immunochemical quantitative analysis of the protein pattern in physiologic and pathologic vitreous.
Clausen R; Weller M; Wiedemann P; Heimann K; Hilgers RD; Zilles K
Graefes Arch Clin Exp Ophthalmol; 1991; 229(2):186-90. PubMed ID: 2044983
[TBL] [Abstract][Full Text] [Related]
6. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
7. [Lactoferrin and transferrin--iron-binding proteins in physiological and pathological vitreous bodies].
Moter H; Weller M; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1990; 87(4):336-9. PubMed ID: 2210558
[TBL] [Abstract][Full Text] [Related]
8. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Capeans C; De Rojas MV; Lojo S; Salorio MS
Retina; 1998; 18(6):546-50. PubMed ID: 9869464
[TBL] [Abstract][Full Text] [Related]
9. [Isoelectric focusing and electroblotting of human vitreous body proteins].
Moter H; Wiedemann P; Weller M; Heimann K
Fortschr Ophthalmol; 1989; 86(4):399-402. PubMed ID: 2793016
[TBL] [Abstract][Full Text] [Related]
10. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
Bresgen M; Weller M; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1990; 87(3):279-82. PubMed ID: 2198204
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the protein pattern in physiologic and pathologic vitreous bodies by electrophoresis and immunologic identification].
Bresgen M; Martiny B; Weller M; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1991; 88(6):665-70. PubMed ID: 1794787
[TBL] [Abstract][Full Text] [Related]
12. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
13. [TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy].
Spranger J; Meyer-Schwickerath R; Klein M; Schatz H; Pfeiffer A
Med Klin (Munich); 1995 Mar; 90(3):134-7. PubMed ID: 7723714
[TBL] [Abstract][Full Text] [Related]
14. Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachment.
Coral K; Angayarkanni N; Madhavan J; Bharathselvi M; Ramakrishnan S; Nandi K; Rishi P; Kasinathan N; Krishnakumar S
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4746-52. PubMed ID: 18566459
[TBL] [Abstract][Full Text] [Related]
15. [Glutamate concentration in diabetic vitreous].
Asensio Sánchez VM; Corral Azor A; Aguirre Aragón B; De Paz García M
Arch Soc Esp Oftalmol; 2003 Sep; 78(9):493-7. PubMed ID: 14517736
[TBL] [Abstract][Full Text] [Related]
16. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
[TBL] [Abstract][Full Text] [Related]
17. [Proliferative vitreoretinopathy. Activation of the complement system].
Grisanti S; Esser P; Weller M; Wiedemann P; Heimann K
Ophthalmologe; 1992 Feb; 89(1):50-4. PubMed ID: 1533804
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
20. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
